Anne Witt

Anne Witt is an executive strategy and corporate development leader, with broad and deep experience across commercial, R&D and transactions. She is leading the enterprise-wide strategy and corporate development team at CSL spanning innovative medicine, plasma therapies and vaccines. Within this global role her team is responsible for informing and executing strategy, strategic partnerships and M&A.

Anne’s career spans across experience in consulting with Boston Consulting Group and PwC as well as corporate at Novartis, Teva and Life Technologies / Thermo Fisher. At BCG she was a core member of the Healthcare practice and focused on advising clients incl. on go-to-market strategies, market access, and business transformations. Previously, she served on the Novartis International Group BD&L and M&A management team leading the enterprise-wide Data and Digital BD&L and Alliance Management team to advance the digital transformation and innovation initiatives. She is passionate about being a change agent and value creator driving integral solutions with cross functional teams.

Anne has a dual academic background in science (MSc., Max Planck Institute) and business (MBA, Harvard Business School).